Thromboelastography to monitor the intra-operative effects of low-molecular weight heparin following bridging anticoagulation in a child with normal renal function

Anaesthesia

Volumn 68, Issue 1, 2013, Pages 91-96

  Casey, M E ^a   Hodges, O ^a   Dunn, R ^b   Thomas, J ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b RED CROSS WAR MEMORIAL CHILDREN S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; FIBRINOGEN; HEPARIN; HEPARIN LYASE; PROTAMINE; WARFARIN;

ADOLESCENT; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; CASE REPORT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; HEPARINIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTRAOPERATIVE PERIOD; KIDNEY FUNCTION; KYPHOSCOLIOSIS; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REACTION TIME; RISK REDUCTION; SPINE SURGERY; THROMBOELASTOGRAPHY; THROMBOEMBOLISM;

EID: 84870992985     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12040     Document Type: Article

References (24)

1. Garcia DA, Baglin TP, Weitz JI, Samama MM,. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis (9th edition): American College of Chest Physicians Evidence- Based Practice Guidelines. Chest 2012; 2 (Suppl.): e24S-43S.
2. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy (9th edition): American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 2 (Suppl.): e326S-50S.
3. Douketis JD, Woods K, Foster GA, Crowther MA,. Bridging anticoagulation with low molecular weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery. Thrombosis and Haemostasis 2005; 94: 528-31. (Pubitemid 41300847)
4. Keeling D, Baglin T, Tait C, et al. Guidelines on oral anticoagulation with warfarin- fourth edition. British Journal of Haematology 2011; 154: 311-24.
5. Chan KL, Summerhayes RG, Ignjatovic V, Horton SB, Monagle PT,. Reference values for kaolin-activated thromboelastography in healthy children. Anesthesia and Analgesia 2007; 105: 1610-3. (Pubitemid 350190554)
6. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 2008; 6 (Suppl.): 299S-339S. (Pubitemid 351894915)
7. Vera-Llonch M, Hagiwara M, Oster G,. Clinical and economic consequences of bleeding following major orthopaedic surgery. Thrombosis Research 2006; 117: 569-77. (Pubitemid 43326144)
8. Spyropoulos AC, Turpie AG, Dunn AS, et al. Perioperative bridging therapy with unfractionated heparin or low molecular weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN registry). American Journal of Cardiology 2008; 102: 883-9.
9. Bounameaux H, de Moerloose P,. Is laboratory monitoring of low-molecular-weight-heparin therapy necessary? No. Journal of Thrombosis and Haemostasis 2004; 2: 551-4. (Pubitemid 40185676)
10. Simons R, Mallett SV,. Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin. Anaesthesia 2007; 62: 1175-8. (Pubitemid 47556423)
11. Klein SM, Slaughter TF, Vail PT, et al. Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations. Anesthesia and Analgesia 2000; 91: 1091-5.
12. Backe SK, Lyons GR,. High-dose tinzaparin in pregnancy and the need for urgent delivery. British Journal of Anaesthesia 2002; 89: 331-4.
13. Jackson GNB, Ashpole KJ, Yentis SM,. The TEG ® vs the ROTEM® thromboelastography/thromboelastometry systems. Anaesthesia 2009; 64: 212-5.
14. Van Ryn- Mckenna J, Cai L, Ofosu FA, Hirsh J, Buchanan MR,. Neutralization of enoxaparine- induced bleeding by protamine sulfate. Thrombosis and Haemostasis 1990; 63: 271-4. (Pubitemid 20128194)
15. Monagle P, Chan AKC, Goldenberg NA, et al. Antithrombotic therapy in neonates and children. Antithrombotic therapy and prevention of thrombosis: 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl.): 737s-801s.
16. Trame MN, Mitchell L, Krümpel A, Male C, Hempel G, Norwal-Göttl U,. Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study. Journal of Thrombosis and Haemostasis 2010; 8: 1950-8.
17. Ignjatovic V, Najid S, Newall F, Summerhayes R, Monagle P,. Dosing and monitoring of enoxaparin (low molecular weight heparin) therapy in children. British Journal of Haematology 2010; 149: 734-8.
18. Hiippala ST, Myllyla GJ, Vahtera EM,. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia 1995; 81: 360-5.
19. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA,. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in-vitro model. British Journal of Anaesthesia 2009; 102: 793-9.
20. Levy JH, Szlam F, Tanaka KA, Sniecienski RM,. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding. Anesthesia and Analgesia 2012; 114: 261-74.
21. Rossaint R, Bouillon B, Cerny V, et al. Management of bleeding following major trauma: an updated European guideline. Critical Care 2010; 14: R52.
22. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrinogen is an early predictor of the severity of postpartum haemorrhage. Journal of Thrombosis and Haemostasis 2007; 5: 266-73. (Pubitemid 46139450)
23. Fenger-Eriksen C, Jensen TM, Kristensen BS, et al. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. Journal of Thrombosis and Haemostasis 2009; 7: 795-802.
24. Schulte A, Clark M,. The effect of line flush heparin contamination on thromboelastograph trace analysis. Anaesthesia 2008; 63: 1381-2.